A University of Manitoba expert is a vital part of an international team of scientists studying the alarming changes in the spread of mpox across the Democratic Republic of Congo (DRC) to better ...

Bavarian Nordic has secured a DKK 200 million+ vaccine contract in Europe, bringing total public‑preparedness deals to over ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

The Democratic Republic of the Congo (DRC) is wrestling with a deepening health crisis as a cholera outbreak hit an "acute phase," compounded by escalating insecurity, a resurgence of mpox, and a ...

Minister of Public Health Roger Kamba told a briefing in Kinshasa, the capital, late Monday that the country remains in the ...

Africa has recorded more than 4,200 deaths due to ongoing cholera and mpox outbreaks in different parts of the continent in ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...

Cholera and mpox outbreaks have killed 4,200 people in different parts of Africa, the Africa Centers for Disease Control and ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The Democratic Republic of the Congo (DRC) is wrestling with a deepening health crisis as a cholera outbreak hit an “acute ...

Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...